Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VicOryx peptide vaccine in advanced HPV-associated cancers
NCT01462838Phase 2Completed
- Start
- Aug 2011
- Primary completion
- Jan 2015
- Modality
- Peptides, Therapeutic Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of P16_37-63 peptide in Cervical Cancer (CC), vulvar cancer, vaginal cancer, penile cancer, anal cancer. Started Aug 2011; status: completed.
02
Drugs
P16_37-63 peptide
03
Conditions
Cervical Cancer (CC)vulvar cancervaginal cancerpenile canceranal cancer
Beyond the preview
Go deeper on NCT01462838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01462838.